Thus these designs will help in reducing the biases and increase the validity of the trial and allow for generalization to similar populations and for policy formulations.

Presence of medical services and medical treatment also should not differ in the two populations. Improved medical treatment in one community will have a positive influence on morbidity and mortality thereby affects the endpoints and evaluation.